Articles From: 2015/1/9 - Adamis Pharmaceuticals Announces Pricing of Public Offering of Common Stock to 2015/1/9 - Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action against Albany Molecular Research, Inc. and Lead Plaintiff Deadline of January 12, 2015


2015/1/9
SAN DIEGO, Jan.
Sign-up for 2015/1/9 - Adamis Pharmaceuticals Announces Pricing of Public Offering of Common Stock investment picks
2015/1/9
Participants Will Learn How to Achieve Virtually 100% Solvent Recovery Using Liquid Nitrogen LEHIGH VALLEY, Pa.
Sign-up for 2015/1/9 - Air Products to Host Webinar on Technology for Controlling VOC Emissions investment picks
2015/1/9
By Charles Passy, MarketWatch Even the Girl Scouts are in on the trend We've heard of gluten-free pizza.
Sign-up for 2015/1/9 - UPDATE: Has gluten-free jumped the shark? investment picks
2015/1/9
By Charles Passy, MarketWatch The bottle: Haig Club, $70 The back story: Sure, we've all heard of single-malt whisky from Scotland, but what about single grain?
Sign-up for 2015/1/9 - If a drink is good enough for David Beckham, is it good enough for you? investment picks
2015/1/9
Meridian Bioscience, Inc., Cincinnati, Ohio (NASDAQ: VIVO) today announced its wholly owned subsidiary, Meridian Life Science, Inc. (MLS) has opened a new office in Beijing, China.
Sign-up for 2015/1/9 - Meridian Opens a New Office in Beijing, China investment picks
2015/1/9
GEORGE TOWN, Grand Cayman, Jan.
Sign-up for 2015/1/9 - Home Loan Servicing Solutions, Ltd. Declares Monthly Dividend of $0.18 Per Ordinary Share for Each of January, February and March 2015 investment picks
2015/1/9
Ultimate Software (Nasdaq: ULTI), a leading cloud provider of people management solutions, announced today that American Software Inc. (Nasdaq: AMSWA), a company that delivers demand-driven supply chain management and enterprise software solutions, is benefiting from UltiPro’s comprehensive human capital management (HCM) capabilities to accelerate processes and improve cost savings as well as enhance flexibility and convenience for employees and managers.
Sign-up for 2015/1/9 - Leading Software Firm Benefits from Human Capital Management in the Cloud, Increased Speed and Flexibility with UltiPro investment picks
2015/1/9
WASHINGTON , Jan.
Sign-up for 2015/1/9 - The Advisory Board Company Completes the Acquisition of Royall & Company investment picks
2015/1/9
Robbins Geller Rudman & Dowd LLP (“Robbins Geller”) ( http://www.rgrdlaw.com/cases/fivebelow/ ) today announced that a class action has been commenced in the United States District Court for the Eastern District of Pennsylvania on behalf of purchasers of Five Below, Inc. (“Five Below”) (NASDAQ:FIVE) common stock during the period between June 5, 2014 and December 4, 2014 (the “Class Period”). If you wish to serve as lead plaintiff, you must move the Court no later than 60 days from today.
Sign-up for 2015/1/9 - Robbins Geller Rudman & Dowd LLP Files Class Action Suit against Five Below, Inc. investment picks
2015/1/9
Levi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the Southern District of New York on behalf of investors who purchased Alcobra Ltd.
Sign-up for 2015/1/9 - UPDATE – UPCOMING DEADLINE: LEVI & KORSINSKY, LLP Notifies Investors of Class Action Against Alcobra Ltd. and Its Board of Directors and a Lead Plaintiff Deadline of January 20, 2015 -- ADHD investment picks
2015/1/9
Emerson (NYSE: EMR) today announced the following senior management appointments and changes, effective after Emerson’s February 3, 2015 board of directors meeting: About Emerson Emerson (NYSE: EMR), based in St.
Sign-up for 2015/1/9 - Emerson Announces Management Appointments investment picks
2015/1/9
BANGALORE, India , January 9, 2015 /PRNewswire/ -- Q3 constant currency revenue growth of 2.6% QoQ; 7.9% YoY Reported revenues at $ 2,218 million ; growth of 0.8% QoQ; 5.6% YoY Operating margins at 26.7%; increase of 60 bps QoQ; 170 bps YoY Net profit at $ 522 million ; growth of 2.2% QoQ; 12.7% YoY Volume growth of 4.2% QoQ (best in 3 years); 11.0% YoY FY 15 revenue guidance maintained 7%-9% at Sep 30 th exchange rates Financial Highlights Consolidated results under International Financial Reporting Standards (IFRS) for the quarter ended December 31, 2014 Quarter ended December 31, 2014 Revenues were $ 2,218 million for the quarter ended December 31, 2014 QoQ growth was 2.6% in constant currency; 0.8% in reported terms; YoY growth was 5.6% Net profit was $ 522 million for the quarter ended December 31, 2014 QoQ growth was 2.2% YoY
Sign-up for 2015/1/9 - Infosys (NYSE: INFY) Announces Results for the Quarter Ended December 31, 2014 investment picks
2015/1/9
HAZARD, FRANKFORT, DANVILLE and LANCASTER, Ky., Jan.
Sign-up for 2015/1/9 - Kentucky First Federal Bancorp Announces Payment of Quarterly Dividend investment picks
2015/1/9
By Marek Fuchs, MarketWatch At this rate, Silicon Valley might be fully integrated within a century or so We had our last laugh of 2014, but the New Year started off on such solid road that laughs are certain to be scarce.
Sign-up for 2015/1/9 - UPDATE: Intel takes a stand on diversity in the city of sin and showgirls investment picks
2015/1/9
The project, worth $1,550 million, includes construction of the plant and 25 years of operation and maintenance.
Sign-up for 2015/1/9 - Abengoa to Develop a 924 MW Plant for Mexico's Federal Electricity Commission investment picks
2015/1/9
Foundation Medicine, Inc. (NASDAQ:FMI) today announced that FoundationOne® , the company's flagship comprehensive genomic profile for patients with solid tumors, successfully identified clinically relevant genomic alterations in 65 percent of patients with lung adenocarcinoma whose tumors previously tested negative for alterations using multiple conventional approaches.
Sign-up for 2015/1/9 - FoundationOne® Identifies High Frequency of Clinically Relevant Genomic Alterations (GA) Previously Missed by Conventional Genomic Tests, Enabling Successful Targeted Treatment in Patients with Non-Small Cell Lung Cancer investment picks
2015/1/9
Retrophin, Inc. (NASDAQ:RTRX) today announced that, based on preliminary, unaudited financial data, the Company expects net product revenue for the fiscal year ended December 31, 2014 of approximately $28.3 million.
Sign-up for 2015/1/9 - Retrophin Provides Corporate Update investment picks
2015/1/9
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1168300&ProfileId=051205&sourceType=1 SEATTLE, WA --
Sign-up for 2015/1/9 - Cray Announces Selected Preliminary 2014 Financial Results investment picks
2015/1/9
ATLANTA, Jan.
Sign-up for 2015/1/9 - Acuity Brands Reports Record First Quarter Results investment picks
2015/1/9
Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announced today that its partner Retrophin, Inc. (NASDAQ:RTRX) has received orphan drug designation from the U.S. Food and Drug Administration (FDA) for Sparsentan for the treatment of focal segmental glomerulosclerosis (FSGS). “Sparsentan has the potential to be a significant medicine, and could transform the treatment of FSGS,” said John Higgins, President and Chief Executive Officer of Ligand Pharmaceuticals.
Sign-up for 2015/1/9 - Ligand Partner Retrophin Receives Orphan Drug Designation for Sparsentan investment picks
2015/1/9
Glu Mobile Inc. (NASDAQ: GLUU), a leading global developer and publisher of free-to-play games for smartphone and tablet devices, today announced that it will report its financial results for the fourth quarter and full year ended December 31, 2014 after the U.S. markets close on Wednesday, February 4, 2015.
Sign-up for 2015/1/9 - Glu Announces Date of Fourth Quarter and Full Year 2014 Financial Results Release, Conference Call, and Webcast investment picks
2015/1/9
ROCK HILL, S.C., Jan.
Sign-up for 2015/1/9 - 3D Systems to Present at the Needham Growth Conference investment picks
2015/1/9
Verint ® Systems Inc. (NASDAQ: VRNT) today announced its participation in the 17 th Annual Needham Growth Conference to be held at The New York Palace Hotel in New York City on January 13-15.
Sign-up for 2015/1/9 - Verint Announces Participation in Upcoming Investor Conference investment picks
2015/1/9
By Jeffry Bartash, MarketWatch Unemployment drops to 5.6% from 5.8%, but wages weaken WASHINGTON (MarketWatch) -- The U.S. added 252,000 new jobs in December to extend the strongest streak of hiring since the mid-1990s, but wages fell and more people dropped out of the labor force to tarnish an otherwise excellent employment report.
Sign-up for 2015/1/9 - UPDATE: U.S. adds 252,000 jobs in December as wages slip investment picks
Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: 2015/1/9 - Adamis Pharmaceuticals Announces Pricing of Public Offering of Common Stock to 2015/1/9 - Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action against Albany Molecular Research, Inc. and Lead Plaintiff Deadline of January 12, 2015
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent